LAUREN ZAMNIAK: Open Payments
NPI 1427666924 · BATAVIA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 23 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $164 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $262 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $198 |
| Regeneron Healthcare Solutions, Inc. | 1 | $135 |
| Edwards Lifesciences Corporation | 2 | $56 |
| SCPHARMACEUTICALS INC. | 2 | $36 |
| Amgen Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: Wegovy, JARDIANCE, EVKEEZA, FUROSCIX, SAPIEN 3 Ultra RESILIA, REPATHA, ONPATTRO, Kerendia.
Industry payments across NY — which companies pay providers there.
